Compare Inovio Pharmaceuticals Inc (INO) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Advanced Drainage Systems Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.76 (market cap $78.55M), while Advanced Drainage Systems Inc trades at $141.14 (market cap $10.83B). The key difference: Advanced Drainage Systems Inc is far larger — about 137.9× Inovio Pharmaceuticals Inc's market cap, and Advanced Drainage Systems Inc pays a 0.56% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | WMS | |
|---|---|---|
Market Cap | $78.55M | $10.83B |
Sector | Health | Industrials |
52-Week High | $2.87 | $175.38 |
52-Week Low | $0.66 | $129.50 |
Enterprise Value | $49.56M | $12.44B |
Dividend Yield | — | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $0.772, up 4.83% in the last 24 hours, but technical indicators signal a bearish trend. The company shows minimal revenue of $65,340 in 2025 with a net loss of $84.95 million, though it has beaten EPS estimates in recent quarters. Key developments include an upcoming Q2 2026 earnings report on August 12, 2026, and a pending FDA decision on INO-3107 by October 30, 2026.
The outlook hinges on FDA approval of INO-3107, with a consensus price target of $3.25 implying significant upside. However, high cash burn, negative margins, and legal scrutiny pose substantial risks. Investors should weigh the binary event against persistent financial challenges.
Advanced Drainage Systems (WMS) trades at $140.13, down 1.09% on the day, amid a bearish technical signal from moving averages. The company demonstrates strong profitability with a 14% net income margin and 24.9% ROE, supported by recent earnings beats. Revenue for fiscal 2025 was $2.90 billion, with cash flow from operations at $581.49 million. Analyst consensus is a Buy with a $185.86 price target, indicating significant upside potential from current levels.
The outlook for WMS is positive based on solid fundamentals and analyst optimism, though near-term technical weakness and competitive pressures pose risks. Investment appeal centers on earnings growth and market leadership in water management solutions, balanced by exposure to construction sector volatility and rising debt levels noted in 2026 projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
